יום שני, כ״ה אלול תשפ״וMonday, September 7, 2026
Follow Us
By JNi.Media
He could have chosen the easy service offered to an outstanding athlete. He preferred, instead, to serve as a combat soldier in the Sayeret Egoz special forces unit.
By JNi.Media
'The results of Talent’s Phase 2 clinical studies are unprecedented, and mark a major milestone in the potential prevention and treatment of this severe and life-threatening disease.'
September 4, 2026 
